Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast CancerHeikki Joensuu, Jorma Isola, Taina Turpeenniemi‐Hujanen et al.|New England Journal of Medicine|2006Cited by 1.4k
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer TrialHeikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono et al.|Journal of Clinical Oncology|2009Cited by 459
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Karl Kieburtz, Shane Rosanbalm et al.|The Lancet Neurology|2023Cited by 128
Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD StudyAndrew McGarry, Michael R. Hayden, Mika Leinonen et al.|Journal of Huntington s Disease|2020Cited by 30
Continuous Levodopa Delivery with an Intraoral Micropump System: An Open‐Label Pharmacokinetics and Clinical StudyC. Warren Olanow, Karl Kieburtz, Michele Matarazzo et al.|Movement Disorders|2024Cited by 11